Structural characterization of plasma metabolites detected via LC-electrochemical coulometric array using LC-UV fractionation, MS, and NMR.

Liquid chromatography (LC) separation combined with electrochemical coulometric array detection (EC) is a sensitive, reproducible, and robust technique that can detect hundreds of redox-active metabolites down to the level of femtograms on column, making it ideal for metabolomics profiling. EC detection cannot, however, structurally characterize unknown metabolites that comprise these profiles. Several aspects of LC-EC methods prevent a direct transfer to other structurally informative analytical methods, such as LC-MS and NMR. These include system limits of detection, buffer requirements, and detection mechanisms. To address these limitations, we developed a workflow based on the concentration of plasma, metabolite extraction, and offline LC-UV fractionation. Pooled human plasma was used to provide sufficient material necessary for multiple sample concentrations and platform analyses. Offline parallel LC-EC and LC-MS methods were established that correlated standard metabolites between the LC-EC profiling method and the mass spectrometer. Peak retention times (RT) from the LC-MS and LC-EC system were linearly related (r(2) = 0.99); thus, LC-MS RTs could be directly predicted from the LC-EC signals. Subsequent offline microcoil-NMR analysis of these collected fractions was used to confirm LC-MS characterizations by providing complementary, structural data. This work provides a validated workflow that is transferrable across multiple platforms and provides the unambiguous structural identifications necessary to move primary mathematically driven LC-EC biomarker discovery into biological and clinical utility.

[1]  S. Rozen,et al.  Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study , 2009, Psychopharmacology.

[2]  Oliver Fiehn,et al.  A comprehensive urinary metabolomic approach for identifying kidney cancerr. , 2007, Analytical biochemistry.

[3]  M. Walsh,et al.  Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. , 2006, The American journal of clinical nutrition.

[4]  Chi-Tang Ho,et al.  Quantitative analysis of ginger components in commercial products using liquid chromatography with electrochemical array detection. , 2010, Journal of agricultural and food chemistry.

[5]  R. Ferrante,et al.  Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease. , 2008, Biochimica et biophysica acta.

[6]  Metabolite identification using a nanoelectrospray LC-EC-array-MS integrated system. , 2008, Analytical chemistry.

[7]  W. Matson,et al.  Metabolomic profiling to develop blood biomarkers for Parkinson's disease. , 2008, Brain : a journal of neurology.

[8]  J. Lindon,et al.  So what's the deal with metabonomics? , 2003, Analytical chemistry.

[9]  M. Beal,et al.  Urinary 8-hydroxy-2′-deoxyguanosine, a Metabolite of Oxidized DNA, is not Elevated in HIV Patients on Combination Antiretroviral Therapy , 2003, Free radical research.

[10]  W. Matson,et al.  n-Electrode three-dimensional liquid chromatography with electrochemical detection for determination of neurotransmitters. , 1984, Clinical chemistry.

[11]  Mark R Viant,et al.  Recent developments in environmental metabolomics. , 2008, Molecular bioSystems.

[12]  Daniel Amador-Noguez,et al.  Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer. , 2010, Analytical chemistry.

[13]  Honglian Shi,et al.  Development of biomarkers based on diet-dependent metabolic serotypes: practical issues in development of expert system-based classification models in metabolomic studies. , 2004, Omics : a journal of integrative biology.

[14]  Jane S. Paulsen,et al.  8OHdG as a marker for Huntington disease progression , 2012, Neurobiology of Disease.

[15]  David S. Wishart,et al.  HMDB: a knowledgebase for the human metabolome , 2008, Nucleic Acids Res..

[16]  M. Beal,et al.  A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods. , 1999, Free radical biology & medicine.

[17]  N. Leymarie,et al.  Identification of phenylbutyrate-generated metabolites in Huntington disease patients using parallel liquid chromatography/electrochemical array/mass spectrometry and off-line tandem mass spectrometry. , 2010, Analytical biochemistry.

[18]  K. Feng,et al.  Determination of nucleotides, nucleosides and their transformation products in Cordyceps by ion-pairing reversed-phase liquid chromatography-mass spectrometry. , 2010, Journal of chromatography. A.

[19]  J. Mathers,et al.  Use of mass spectrometry fingerprinting to identify urinary metabolites after consumption of specific foods. , 2011, The American journal of clinical nutrition.

[20]  Douglas B. Kell,et al.  Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets , 2011, Bioinform..

[21]  Ugo Paolucci,et al.  Development of biomarkers based on diet-dependent metabolic serotypes: concerns and approaches for cohort and gender issues in serum metabolome studies. , 2004, Omics : a journal of integrative biology.

[22]  M. Keshavan,et al.  3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. , 2011, The international journal of neuropsychopharmacology.

[23]  Mark R Viant,et al.  Metabolomics of microliter hemolymph samples enables an improved understanding of the combined metabolic and transcriptional responses of Daphnia magna to cadmium. , 2011, Environmental science & technology.

[24]  W. Matson,et al.  Simultaneous analysis of the majority of low-molecular-weight, redox-active compounds from mitochondria. , 1998, Analytical biochemistry.

[25]  O. Fiehn,et al.  Determination of elemental compositions by gas chromatography/time-of-flight mass spectrometry using chemical and electron ionization. , 2010, Rapid communications in mass spectrometry : RCM.

[26]  M. Keshavan,et al.  Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naïve Patients with Schizophrenia , 2010, PloS one.

[27]  R. Kaddurah-Daouk,et al.  Metabolomics in the study of aging and caloric restriction. , 2007, Methods in molecular biology.

[28]  W. Matson,et al.  Characterization of diet-dependent metabolic serotypes: proof of principle in female and male rats. , 2002, The Journal of nutrition.

[29]  R. Weinshilboum,et al.  Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.

[30]  M. Beal,et al.  Increased oxidative damage to DNA in ALS patients. , 2000, Free radical biology & medicine.

[31]  Wayne R Matson,et al.  Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice. , 2006, Biochimica et biophysica acta.

[32]  W. Drevets,et al.  Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile , 2012, Scientific Reports.

[33]  R. Kaddurah-Daouk,et al.  High-Performance Liquid Chromatography Separations Coupled With Coulometric Electrode Array Detectors , 2007 .

[34]  R. Krishnan,et al.  Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept , 2011, Translational Psychiatry.

[35]  Zilin Chen,et al.  Simultaneous determination of tetrandrine and fangchinoline in herbal medicine Stephania tetrandra S. Moore by liquid chromatography with electrochemical detection. , 2012, Journal of pharmaceutical and biomedical analysis.

[36]  Mark R Viant,et al.  Direct sampling of organisms from the field and knowledge of their phenotype: key recommendations for environmental metabolomics. , 2007, Environmental science & technology.

[37]  M. Beal,et al.  Metabolomic Profiling in LRRK2-Related Parkinson's Disease , 2009, PloS one.

[38]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[39]  J. Sweedler,et al.  High-resolution microcoil NMR for analysis of mass-limited, nanoliter samples. , 1998, Analytical chemistry.

[40]  A. Moskowitz,et al.  Purine catabolism: links to mitochondrial respiration and antioxidant defenses? , 1999, Archives of biochemistry and biophysics.

[41]  Ugo Paolucci,et al.  Development of biomarkers based on diet-dependent metabolic serotypes: characteristics of component-based models of metabolic serotypes. , 2004, Omics : a journal of integrative biology.

[42]  M. Beal,et al.  N ε ‐(γ‐l‐Glutamyl)‐l‐lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington's disease , 2001 .

[43]  Wayne R Matson,et al.  Simultaneous analysis of multiple redox-active metabolites from biological matrices. , 2002, Methods in molecular biology.

[44]  Xianlin Han,et al.  Metabolomic changes in autopsy-confirmed Alzheimer's disease , 2011, Alzheimer's & Dementia.

[45]  Oliver Fiehn,et al.  Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry , 2007, BMC Bioinformatics.

[46]  W. Willett,et al.  Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome , 2006, BMC clinical pathology.

[47]  S. Rozen,et al.  Metabolomic analysis and signatures in motor neuron disease , 2005, Metabolomics.

[48]  Karen E Vigneau-Callahan,et al.  Characterization of diet-dependent metabolic serotypes: primary validation of male and female serotypes in independent cohorts of rats. , 2002, The Journal of nutrition.

[49]  A. Saghatelian,et al.  Exploring disease through metabolomics. , 2010, ACS chemical biology.

[50]  J. Mathers,et al.  Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption. , 2011, The British journal of nutrition.

[51]  C. Tanner,et al.  Urate as a predictor of the rate of clinical decline in Parkinson disease. , 2009, Archives of neurology.

[52]  R. Abagyan,et al.  METLIN: A Metabolite Mass Spectral Database , 2005, Therapeutic drug monitoring.